This leaflet is about the use of fluconazole for the treatment and prevention of certain yeast and fungal infections. This leaflet has been written specifically for parents and carers about the use of this medicine in children. Our information sometimes differs from that provided by the manufacturer, because their information is usually aimed at adult patients. Keep it somewhere safe so that you can read it again. Fluconazole Brand names: Diflucan® Your child has an infection caused by a yeast or fungus. Fluconazole causes damage to the membrane of yeast and fungal cells and stops the cells growing and multiplying. This gets rid of the infection, or stops an infection from developing. Some of the yeast or fungus may remain after the infection has gone. However, in babies this may be once every two or three days. Fluconazole is a type of medicine called a triazole antifungal. It kills fungi and yeasts by interfering with their cell membranes. Fluconazole works by stopping fungi and yeasts from producing a substance called ergosterol, which is an essential component of their cell membranes. Fluconazole causes holes to appear in the cell membranes, which allows essential constituents of the fungal or yeast cells to leak out. This kills the fungi or yeast, which either clears up the infection or prevents it from developing. Fluconazole is used to treat and prevent a number of different types of fungal and yeast infections, particularly those caused by Candida or Cryptococcus species of fungi. Fluconazole can be taken by mouth (as capsules or suspension) or may be administered via a drip into a vein (intravenous infusion) depending on the type and severity of the infection. The length of treatment needed depends on the type and severity of the infection.
Jack L Lesher, Jr, MD Chief, Professor, Department of Internal Medicine, Section of Dermatology, Medical College of Georgia Jack L Lesher, Jr, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, Medical Association of Georgia, Society for Investigative Dermatology, Southern Medical Association Disclosure: Nothing to disclose. Richard P Vinson, MD Assistant Clinical Professor, Department of Dermatology, Texas Tech University Health Sciences Center, Paul L Foster School of Medicine; Consulting Staff, Mountain View Dermatology, PA Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Texas Medical Association, Association of Military Dermatologists, Texas Dermatological Society Disclosure: Nothing to disclose. Rosalie Elenitsas, MD Herman Beerman Professor of Dermatology, University of Pennsylvania School of Medicine; Director, Penn Cutaneous Pathology Services, Department of Dermatology, University of Pennsylvania Health System Rosalie Elenitsas, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, American Society of Dermatopathology, Pennsylvania Academy of Dermatology Disclosure: Received royalty from Lippincott Williams Wilkins for textbook editor. Dirk M Elston, MD Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology Disclosure: Nothing to disclose. Janet Fairley, MD Professor and Head, Department of Dermatology, University of Iowa, Roy J and Lucille A Carver College of Medicine Janet Fairley, MD is a member of the following medical societies: American Academy of Dermatology, American Federation for Medical Research, Society for Investigative Dermatology Disclosure: Nothing to disclose. The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous authors Mary Elizabeth Rushing Lott, MD and Gwendolyn Zember, MD, to the development and writing of this article. It looks like you are trying to access 1800Pet Meds from a country in the EU. Due to the GDPR we are unable to accept your business at this time. Please check back from time to time for updates on our policy. If you are in the United States or Canada and believe you have reached this page in error, make sure to disable any VPN or Proxy services you might be using to access our site. If you are seeking Investor information, you can find our Investor Site by following this link.
All patients were given a single 150-mg dose of fluconazole upon entry into the study; at that time, and at each follow-up visit, clinical signs and symptoms were. Skin infections - e.g. athlete's foot, ringworm, jock itch, nail infection. You can continue breast-feeding after taking a single dose of Fluconazole up to 200 mg.